• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻二酚(CBD)的主要治疗应用及其对阿尔茨海默病相关衰老的潜在影响。

The Main Therapeutic Applications of Cannabidiol (CBD) and Its Potential Effects on Aging with Respect to Alzheimer's Disease.

机构信息

International Clinical Research Centre, Cannabis Facility, St. Anne's University Hospital, Pekařská 53, 602 00 Brno, Czech Republic.

Department of Pharmacology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic.

出版信息

Biomolecules. 2023 Sep 26;13(10):1446. doi: 10.3390/biom13101446.

DOI:10.3390/biom13101446
PMID:37892128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10604144/
Abstract

The use of cannabinoids (substances contained specifically in hemp plants) for therapeutic purposes has received increased attention in recent years. Presently, attention is paid to two main cannabinoids: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). With respect to the psychotropic effects and dependence potential of THC (though it is very mild), its use is associated with certain restrictions, and thus the therapeutic properties of CBD are frequently emphasized because there are no limitations associated with the risk of dependence. Therefore, this review covers the main pharmacodynamic and pharmacokinetic features of CBD (including characteristics of endocannabinoidome) with respect to its possible beneficial effects on selected diseases in clinical practice. A substantial part of the text deals with the main effects of CBD on aging, including Alzheimer's disease and related underlying mechanisms.

摘要

近年来,大麻素(大麻植物中特有的物质)在治疗中的应用引起了越来越多的关注。目前,人们主要关注两种大麻素:Δ-9-四氢大麻酚(THC)和大麻二酚(CBD)。鉴于 THC 的精神活性作用和潜在依赖性(尽管非常轻微),其使用受到某些限制,因此经常强调 CBD 的治疗特性,因为不存在与依赖性风险相关的限制。因此,本综述涵盖了 CBD 的主要药效学和药代动力学特征(包括内源性大麻素组的特征),以及其在临床实践中对某些疾病可能产生的有益作用。文本的很大一部分涉及 CBD 对衰老的主要影响,包括阿尔茨海默病和相关的潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0822/10604144/474d20fd31a0/biomolecules-13-01446-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0822/10604144/16659e06425a/biomolecules-13-01446-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0822/10604144/474d20fd31a0/biomolecules-13-01446-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0822/10604144/16659e06425a/biomolecules-13-01446-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0822/10604144/474d20fd31a0/biomolecules-13-01446-g002.jpg

相似文献

1
The Main Therapeutic Applications of Cannabidiol (CBD) and Its Potential Effects on Aging with Respect to Alzheimer's Disease.大麻二酚(CBD)的主要治疗应用及其对阿尔茨海默病相关衰老的潜在影响。
Biomolecules. 2023 Sep 26;13(10):1446. doi: 10.3390/biom13101446.
2
Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.利用 BMD 方法推导与电子烟液相关的可接受的大麻二酚(CBD)和四氢大麻酚(THC)日摄入量。
Front Biosci (Landmark Ed). 2022 Jul 25;27(8):228. doi: 10.31083/j.fbl2708228.
3
The Cannabinoids, CBDA and THCA, Rescue Memory Deficits and Reduce Amyloid-Beta and Tau Pathology in an Alzheimer's Disease-like Mouse Model.大麻素、CBDA 和 THCA 可挽救阿尔茨海默病样小鼠模型的记忆缺陷,并减少淀粉样-β和 Tau 病理。
Int J Mol Sci. 2023 Apr 6;24(7):6827. doi: 10.3390/ijms24076827.
4
Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.分别及联合使用Δ⁹-四氢大麻酚和大麻二酚对大鼠可变间隔行为表现的影响。
Braz J Med Biol Res. 1983 Jul;16(2):141-6.
5
Effects of Chronic, Low-Dose Cannabinoids, Cannabidiol, Delta-9-Tetrahydrocannabinol and a Combination of Both, on Amyloid Pathology in the 5xFAD Mouse Model of Alzheimer's Disease.慢性、低剂量大麻素、大麻二酚、Δ9-四氢大麻酚及其组合对阿尔茨海默病 5xFAD 小鼠模型淀粉样蛋白病理的影响。
Cannabis Cannabinoid Res. 2024 Oct;9(5):1312-1325. doi: 10.1089/can.2023.0101. Epub 2023 Oct 20.
6
The anxiolytic effects of cannabinoids: A comprehensive review.大麻素的抗焦虑作用:全面综述。
Pharmacol Biochem Behav. 2024 Oct;243:173828. doi: 10.1016/j.pbb.2024.173828. Epub 2024 Jul 18.
7
Approved cannabinoids for medical purposes - Comparative systematic review and meta-analysis for sleep and appetite.经批准用于医疗目的的大麻素 - 睡眠和食欲的比较系统评价和荟萃分析。
Neuropharmacology. 2021 Sep 15;196:108680. doi: 10.1016/j.neuropharm.2021.108680. Epub 2021 Jun 26.
8
Cannabinoids: Therapeutic Use in Clinical Practice.大麻素:临床实践中的治疗用途。
Int J Mol Sci. 2022 Mar 19;23(6):3344. doi: 10.3390/ijms23063344.
9
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.δ-9-四氢大麻酚、大麻二酚及其组合对面部表情识别的急性影响:一项针对大麻使用者的随机、双盲、安慰剂对照研究。
Eur Neuropsychopharmacol. 2015 Mar;25(3):325-34. doi: 10.1016/j.euroneuro.2014.11.014. Epub 2014 Dec 5.
10
A randomised controlled trial of vaporised Δ-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.一项随机对照试验研究了在频繁和不频繁使用大麻的人群中单独使用和联合使用蒸气化 Δ-四氢大麻酚和大麻二酚的效果:急性中毒效应。
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):17-35. doi: 10.1007/s00406-019-00978-2. Epub 2019 Jan 19.

引用本文的文献

1
Cannabis (THC) Aggravates the Deleterious Effects of Alcohol (EtOH) on Skeletal Muscles' Mitochondrial Respiration: Modulation by Age and Metabolic Phenotypes.大麻(THC)加剧酒精(EtOH)对骨骼肌线粒体呼吸的有害影响:年龄和代谢表型的调节作用
Biology (Basel). 2024 Dec 21;13(12):1080. doi: 10.3390/biology13121080.
2
Modulation of Oxidative Stress and Neuroinflammation by Cannabidiol (CBD): Promising Targets for the Treatment of Alzheimer's Disease.大麻二酚(CBD)对氧化应激和神经炎症的调节作用:治疗阿尔茨海默病的潜在靶点
Curr Issues Mol Biol. 2024 May 6;46(5):4379-4402. doi: 10.3390/cimb46050266.

本文引用的文献

1
The Effect of Cannabidiol 3% on Neuropsychiatric Symptoms in Dementia - Six-Month Follow-Up.CBD3% 对痴呆症神经精神症状的影响 - 六个月随访。
Clin Gerontol. 2024 Oct-Dec;47(5):800-807. doi: 10.1080/07317115.2023.2209563. Epub 2023 May 8.
2
Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis.大麻二酚相关肝毒性:一项系统评价与荟萃分析。
J Intern Med. 2023 Jun;293(6):724-752. doi: 10.1111/joim.13627. Epub 2023 Mar 13.
3
Systematic literature review of human studies assessing the efficacy of cannabidiol for social anxiety.
评估大麻二酚治疗社交焦虑症疗效的人体研究的系统文献综述。
Psychiatry Res Commun. 2022 Dec;2(4). doi: 10.1016/j.psycom.2022.100074. Epub 2022 Sep 13.
4
Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance.大麻二酚:抗氧化作用、细胞保护与认知及身体机能之间的桥梁
Antioxidants (Basel). 2023 Feb 14;12(2):485. doi: 10.3390/antiox12020485.
5
Effects of rich cannabidiol oil on behavioral disturbances in patients with dementia: A placebo controlled randomized clinical trial.富含大麻二酚油对痴呆患者行为障碍的影响:一项安慰剂对照随机临床试验。
Front Med (Lausanne). 2022 Sep 6;9:951889. doi: 10.3389/fmed.2022.951889. eCollection 2022.
6
Assessment of delta-9-tetrahydrocannabinol (THC) in saliva and blood after oral administration of medical cannabis with respect to its effect on driving abilities.评估口服医用大麻后唾液和血液中的大麻酚(Δ-9-四氢大麻酚)及其对驾驶能力的影响。
Physiol Res. 2022 Nov 28;71(5):703-712. doi: 10.33549/physiolres.934907. Epub 2022 Sep 19.
7
Review: Cannabinoids as Medicinals.综述:大麻素作为药物
Curr Addict Rep. 2022;9(4):630-646. doi: 10.1007/s40429-022-00438-3. Epub 2022 Sep 7.
8
Cannabidiol as a Treatment for Neurobiological, Behavioral, and Psychological Symptoms in Early-Stage Dementia: A Double-Blind, Placebo-Controlled Clinical Trial Protocol.大麻二酚作为早期痴呆症神经生物学、行为和心理症状的治疗方法:一项双盲、安慰剂对照临床试验方案。
Cannabis Cannabinoid Res. 2023 Apr;8(2):348-359. doi: 10.1089/can.2021.0209. Epub 2022 Aug 30.
9
Cannabidiol for Treatment-Resistant Anxiety Disorders in Young People: An Open-Label Trial.大麻二酚治疗青少年治疗抵抗性焦虑障碍:一项开放性试验。
J Clin Psychiatry. 2022 Aug 3;83(5):21m14130. doi: 10.4088/JCP.21m14130.
10
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?大麻二酚治疗自闭症谱系障碍:希望还是炒作?
Psychopharmacology (Berl). 2022 Sep;239(9):2713-2734. doi: 10.1007/s00213-022-06196-4. Epub 2022 Jul 29.